Life Sciences Invest. Partnering Russia. Results - 2016

Within the forum the ceremonial opening of the Center of superiority for development of innovative medicines and technologies including the center of a transfer of technologies and a GMP training the center was held. Opening of the Center will allow SPHFA to realize research and educational potential effectively. Sergey Movchan, the vice governor of St. Petersburg, Maxim Meyksin, the chairman of Committee on industrial policy and innovations of St. Petersburg, Igor Narkevich, фарм.н became participants., professor, rector of SPHFA.

"Priorities in development of a domestic health system" were discussed key questions of development of a cluster in St. Petersburg at a plenary session and system of measures of the state support. As the moderator the director of the Union "Medico-pharmaceutical projects acted. 21st century" Dmitry Chagin. The Secretary of State of the Ministry of Economics, construction and tourism of the earth Mecklenburg Lobby Pomerania Rudolf Stefan took part in discussion of questions.

Participants of a thematic session "Innovative approach in preparation of pharmaceutical and medical shots" discussed accreditation of specialists, professional standards, modern educational programs, system of continuous education in medicine and pharmacy. The rector SPHFA Igor Narkevich acted as the moderator. As speakers specialists of leading companies – Aleksandra Glazkova, the deputy CEO for human resource management of JSC Biocad, Leon Kogan, the director of production of the Veropharm company Abbot, Maria Gurulyova, the deputy CEO for human resource management of LLC NTFF POLISANG, Elena Mukhacheva, the area manager of corporate programs Pfizer acted.

During the session participants also got acquainted with how at the moment there is an accreditation ekzamenation of specialists druggists. The executive director of the Union "National Pharmaceutical Chamber" (NPC) Elena Nevolina considers that the available format of examination needs completions. "In 2017 examination will take place in a former format. But now we raise for the Ministry of Health a question of that it was changed". According to her, offers on organizational issues of carrying out accreditation came to NFP. For example, the question of need of accurate fixing of responsibility of members of the accreditation commission is discussed.

Within the session solemn signing of the Agreement on cooperation in the field of training between FGBOOU WAUGH "The St. Petersburg state chemical and pharmaceutical academy" of the Ministry of Health of the Russian Federation and the L'Oréal company took place.

During the thematic session "Development of system of rendering the hi-tech help in the Russian Federation. Support of the innovative companies in the field of health care, including measures of non-financial character" in St. Petersburg told participants about development of the hi-tech medical care (HTMC) the vice-chairman of Healthcare Committee Yana Kabushka. She reminded that according to "May Decrees" of the Russian President of May 7, 2012 VMP volume in the region had to grow in three years not less, than by one and a half times. "For St. Petersburg this indicator is exceeded: VMP volume in three years increased by 162%" — the representative of department noted. She emphasized that in 2016 more than 2 billion rubles will be directed to these purposes.

In discussion of questions the chairman of the board of LLC LDTs MIBS im. Sergeya Berezina group of companies Arkady Stolpner, and also Yuli Mikheyev's speakers, the director of the department of social development of the Ministry of Economic Development of the Russian Federation acted as the moderator; Lubov Butina, head of department of the compulsory health insurance organization GU "Territorial Fund of Obligatory Medical Insurance of St. Petersburg"; Vladimir Volchkov, chief physician of the Municipal multi-field hospital No. 2, MD, professor, Honored doctor of the Russian Federation.

The attention of participants of a round table "System of inspection of pharmaceutical production" was drawn by a question of harmonization of rules of good manufacturing practice with the urgent rules GMP EU, and also possibilities of holding joint inspections with WHO, PIC/s, foreign inspectorates, a possibility of harmonization of procedures of inspection. The director of FBU "The State Institute of Medicines and Ought the Practician", Vladislav Shestakov acted as the moderator of a session. Authorities, namely the head of department of licensing of production of medicines of Development department of the pharmaceutical and medical industry of the Ministry of Industry and Trade of the Russian Federation Elena Denisova, and also the representative of Republic of Belarus – Alla Dolgolikova, the consultant of department of pharmaceutical inspection of the Ministry of Health of RB took part in discussion.

During a round table of "An innovation of pharmacology and toxicology" participants paid special attention to requirements to preclinical toksilogichesky and pharmacological trials. Practically each speaker placed emphasis that without careful carrying out preclinical trials it is impossible to release a product. In particular the CEO of CJSC St. Petersburg Institute of Pharmacy Valery Makarov told: "It is necessary to check at first in laboratory substance, and then already to be engaged in release of tablets".

Participants of a round table "Philosophy of management of an oncological disease: manufacturing doctor-patient-society" under the auspices of regional public organization "Doctors of St. Petersburg" was discussed by key questions on the organization of the oncological help in St. Petersburg.

In addition to substantive sessions, the closed action of the Ernst & Young (EY) company, an exit meeting of the working group on health care and pharmaceutics of the Advisory board on foreign investments in Russia (KSII) took place.

During the meeting of Scientific and technical council "Future pharmacy" of the Technological platform "Future Medicine" the head of department of new production technologies of department of science and technologies of the Ministry of Education and Science of the Russian Federation Alexey Syomin made the report on development of innovative medical technologies in regions. According to him, the greatest success manages to be achieved where pharmaceutical clusters, but not separate productions work. Besides, during the discussion participants discussed questions of formation of the program of the Union State, and formation of offers on preclinical trials of innovative medicines.

Opening a thematic session "Harmonization of Requirements to Drug Circulation within the Eurasian Economic Union", the chairman of the board of NP Union of Pharmaceutical and Biomedical Clusters Zakhar Golant noted positive changes in work of departments whose activity affects the field of pharmacology. "If till 2010 each of the ministries conducted own policy, then since 2010 we see more intensive communication between the Ministry of Health and other ministries and departments, each of which is responsible for the block of questions. We also see a large number of the made changes in the legislation", - Zakhar Golant told.

Within a round table "Development of the pharmaceutical industry on the basis of innovative territorial and industrial clusters. The international interaction", speakers acted the CEO of JSC The Agency of Innovative Development — the Center of Cluster Development of the Kaluga Region Anatoly Sotnikov; chairman of the board of directors of SOOO "NATIVITA" (Republic of Belarus); deputy head of the department of innovative pharmaceutics and biotechnology, executive director of NP Center of Development of BFK Severny, Oleg Korzinov.

Before a round table of "An innovation in medicine" the president of the Russian cardiological society Evgeny Shlyakhto urged to analyze results of implementation of innovations carefully. "Involvement of new partners, feedback, the analysis of progress and failures — the fact that will allow us to combine a transmitting and innovative cycle today and to develop further" — he noted.

Within the forum the German company Bayer and the Russian firm "Polisang" signed the agreement on cooperation increase, on production in St. Petersburg of X-ray contrast agents.

According to the CEO of the foreign company Niels Hessmann, "The production of drugs in Russia will allow to provide with them about 200 thousand patients. It will help to avoid more than five thousand strokes". The contract will work within 10 years, however the CEO of the Polisang company Alexander Borisov does not doubt that after the termination of term the agreement will be prolonged.

Within the thematic session "Innovations in Pharmacy", a discussion the question of development of innovative dosage forms and technologies of their receiving with the subsequent transfer of results of scientific research in pharmaceutical production underwent. As one of speakers Elena Zhilyakova, фарм.н acted., professor, department chair of pharmaceutical technology, FGAOU VPO "The Belgorod state national research university". Andrey Teslev, the director of the Center of the SPHFA Pharmaceutical Technology, reported that they in TsFT already developed several unique drugs. "We created the medicine possessing anti-ischemic actions. Our Center developed several kinds of this drug – solutions for injections and a tablet in a firm cover", - Andrey Teslev told. He also added that development of these and other medicines is carried out within state contracts.

Comments of participants of the Forum

1. Sergey Movchan: St. Petersburg – the pharmaceutical capital of Russia

St. Petersburg is one of leaders in production of pharmaceutical drugs and the medical equipment in Russia that allows to attract the foreign companies to the country. Such opinion in the first day of a forum, on November 9, was stated by the vice governor of St. Petersburg Sergey Movchan. "In St. Petersburg more than 150 companies which are engaged in production pharmaceutical drugs and the medical equipment work. On this indicator we in the forefront, among all regions of Russia", - Movchan noted.

According to the vice governor of St. Petersburg, a set of the foreign companies are interested in cooperation with the pharmaceutical enterprises of St. Petersburg. He also noted that on a forum the whole package of proposals from the German companies interested not only on entry of the drugs and the equipment into the Russian market, but also persons interested to organize production in the territory of St. Petersburg and other territory of Russia is brought.

Let's remind, the VI partnering-forum Life Sciences Invest. Partnering Russia passes on November 9-10. The organizer of a forum — the Union "Medico-pharmaceutical projects. 21st century". The action is traditionally supported by Committee on industrial policy and innovations of St. Petersburg, the Ministry of Economic Development, the Ministry of the industry and trade, the Ministry of Health of the Russian Federation, and also the Government of St. Petersburg. Partners of a forum – MSD Pharmaceuticals, LLC Novo Nordisk, CJSC Generium, LLC Samson-Med and NTFF "Polisang".

2. Dmitry Chagin: In the center of the forum Life Sciences Invest. Partnering Russia cost not questions of import substitution, but an importooperezheniya any more

In the center of attention of the VI partnering-forum Life Sciences Invest. Partnering Russia are not questions of import substitution in the pharmaceutical industry any more, and an importooperezheniya. Such point of view in the first day of a forum, on November 9, the director of the Union "Stated medico-pharmaceutical projects. 21st century" Dmitry Chagin.

"The forum takes place the sixth time. We collect questions which we discuss at a forum all year from our pharmaceutical actions. It and interaction with patient community, questions of breakthrough technologies, questions of a transfer of technologies, educational programs, events around the St. Petersburg state chemical and pharmaceutical academy, implementation of our profile Pharma-2020 program", - Chagin noted.

According to the director of the Union, the sanction and a foreign policy situation did not reduce intensity of the international cooperation within the forum. As an example it gave signing on the platform of an action of the agreement between the Bayer and Polisang companies on production of contrast agent on the platform of the St. Petersburg action.

Let's remind, the VI partnering-forum Life Sciences Invest. Partnering Russia passes on November 9-10. The organizer of a forum — the Union "Medico-pharmaceutical projects. 21st century". The action is traditionally supported by Committee on industrial policy and innovations of St. Petersburg, the Ministry of Economic Development, the Ministry of the industry and trade, the Ministry of Health of the Russian Federation, and also the Government of St. Petersburg. Partners of a forum – MSD Pharmaceuticals, LLC Novo Nordisk, CJSC Generium, LLC Samson-Med and NTFF "Polisang".

3. Head Geropharm: Forum Life Sciences Invest. Partnering Russia became tradition

The VI Forum Life Sciences Invest which is taking place on November 9-10 in St. Petersburg. Partnering Russia became good tradition. About it journalists were told by the CEO of Geropharm Group Pyotr Rodionov.

"The forum became already traditional autumn meeting which is devoted to our achievements and calls, facing us. We successfully discuss them here not only at the city level, but also with representatives of federal departments. During the Forum Life Sciences Invest. Partnering Russia form a certain vision and the strategy of development for the industry in general", - the head of Geropharm is sure.

He also noted that the Forum is extremely important for business that it confirms participation in it of the leading players of the pharmaceutical industry.

Let's remind, the VI partnering-forum Life Sciences Invest. Partnering Russia passes on November 9-10. The organizer of a forum — the Union "Medico-pharmaceutical projects. 21st century". The action is traditionally supported by Committee on industrial policy and innovations of St. Petersburg, the Ministry of Economic Development, the Ministry of the industry and trade, the Ministry of Health of the Russian Federation, and also the Government of St. Petersburg. Partners of a forum – MSD Pharmaceuticals, LLC Novo Nordisk, CJSC Generium, LLC Samson-Med and NTFF "Polisang".

4. Maxim Meyksin: Pharmaceutics - "business card" of St. Petersburg

The pharmaceutical industry became "hallmark" of St. Petersburg. About it during the VI partnering-forum Life Sciences Invest. Partnering Russia the chairman of Committee on industrial policy and innovations Maxim Meyksin declared to journalists.

"We see that the pharmaceutical industry - one of drivers of development of the industry, technologies and innovations in the city. A forum - an opportunity to meet, look what new appeared, to share opinions, to create the agenda", - Meyksin told.

He added that for representatives of executive authorities the Forum became the platform on which it is possible to develop the most effective measures of support of the pharmaceutical industry.

During the Forum the chairman of Committee also took part in work of a thematic session "Development of system of rendering the hi-tech help in the Russian Federation. Support of the innovative companies in the field of health care, including measures of non-financial character" Maxim Meyksin told about development of this direction in St. Petersburg. He listed already existing measures of support of the industry and permanent bodies — Industrial council at the governor and Public council at Committee on industrial policy and innovations of St. Petersburg.

Let's remind, the VI partnering-forum Life Sciences Invest. Partnering Russia passes on November 9-10. The organizer of a forum — the Union "Medico-pharmaceutical projects. 21st century". The action is traditionally supported by Committee on industrial policy and innovations of St. Petersburg, the Ministry of Economic Development, the Ministry of the industry and trade, the Ministry of Health of the Russian Federation, and also the Government of St. Petersburg. Partners of a forum – MSD Pharmaceuticals, LLC Novo Nordisk, CJSC Generium, LLC Samson-Med and NTFF "Polisang".

5. Irina Babyuk: St. Petersburg - the leader of investment projects in the field of health care

In recent years St. Petersburg became the leader in implementation of investment projects in the field of health care. About it at opening of the VI annual international partnering-forum Life Sciences Invest. Partnering Russia was told by the chairman of committee on investments of St. Petersburg Irina Babyuk.

"In St. Petersburg is implemented unique investment projects now. It is the rehabilitation center on the basis of the 40th hospital, the innovative and diagnostic center in Pushkina academies, it is the center of proton radiation therapy which opening is as follows to year" — added Babyuk.

The head of committee also added that from the point of view of creation of investment climate, it is possible to call it the real break. Babyuk also hoped that the opened forum will help to fix and increase a tendency of development of a pharmaceutical cluster in St. Petersburg.

Let's remind, the VI partnering-forum Life Sciences Invest. Partnering Russia passes on November 9-10. The organizer of a forum — the Union "Medico-pharmaceutical projects. 21st century". The action is traditionally supported by Committee on industrial policy and innovations of St. Petersburg, the Ministry of Economic Development, the Ministry of the industry and trade, the Ministry of Health of the Russian Federation, and also the Government of St. Petersburg. Partners of a forum – MSD Pharmaceuticals, LLC Novo Nordisk, CJSC Generium, LLC Samson-Med and NTFF "Polisang".

6. Rudolf Stefan: Forum Life Sciences Invest. Partnering Russia makes an enormous impression

VI partnering-forum Life Sciences Invest. Partnering Russia is an important event in the pharmaceutical industry and makes an enormous impression. It during opening of the Forum was declared by the Secretary of State of the Ministry of Economics, construction and tourism of the State of Mecklenburg — Front Pomerania Rudolf Stefan.

"The vice governor of St. Petersburg Sergey Movchan already said today that each of participants of the Forum in the workplace and owing to the opportunities does everything to provide health of the nation that each citizen felt provided in respect of health care. And I agree with it. On the one hand, it would be possible to consider that what occurs within the walls of the Forum is only exchange of experience, but actually the horizons are much wider. Each of attendees has chance to make something good for the fellow citizens, and for representatives of Germany huge honor to make also the contribution to it. It is about increase in life expectancy of citizens of Russia", - Stefan told.

The Secretary of State of the Ministry of Economics, construction and tourism of the State of Mecklenburg — Front Pomerania in the welcome speech emphasized importance of the international cooperation between Russia and Germany. Rudolf Shteffan especially emphasized efforts of the authorities of St. Petersburg which were made in this direction in recent years.

Let's remind, the VI partnering-forum Life Sciences Invest. Partnering Russia passes on November 9-10. The organizer of a forum — the Union "Medico-pharmaceutical projects. 21st century". The action is traditionally supported by Committee on industrial policy and innovations of St. Petersburg, the Ministry of Economic Development, the Ministry of the industry and trade, the Ministry of Health of the Russian Federation, and also the Government of St. Petersburg. Partners of a forum – MSD Pharmaceuticals, LLC Novo Nordisk, CJSC Generium, LLC Samson-Med and NTFF "Polisang".

7. Head of BIOCAD: The Russian pharma has big perspectives in the foreign markets

The Russian pharmaceutical industry has big perspectives in the foreign markets, including - western. Expressed such opinion to journalists during the VI partnering-forum Life Sciences Invest. Partnering Russia CEO of BIOCAD Dmitry Morozov.

"All countries which care for the state of health of the nation have to be interested in the Russian pharmaceutical products. Especially it akualno in connection with not the most favorable situation in developing countries and some developed countries. If we look at Western Europe, then there the governments very strongly try to reduce costs of health care, appetites of local producers are too huge there", - told

In his opinion, the Russian products do not concede on the quality. At the same time the cost of domestic drugs it is notable below.

Dmitry Morozov also added that such actions as the Forum Life Sciences Invest. Partnering Russia promote development of the industry. "The forum is organized top-level, we calculate that there will be many interesting meetings and useful contacts", - the head of BIOCAD emphasized in a conversation with journalists.

Let's remind, the VI partnering-forum Life Sciences Invest. Partnering Russia passes on November 9-10. The organizer of a forum — the Union "Medico-pharmaceutical projects. 21st century". The action is traditionally supported by Committee on industrial policy and innovations of St. Petersburg, the Ministry of Economic Development, the Ministry of the industry and trade, the Ministry of Health of the Russian Federation, and also the Government of St. Petersburg. Partners of a forum – MSD Pharmaceuticals, LLC Novo Nordisk, CJSC Generium, LLC Samson-Med and NTFF "Polisang".

8. Zakhar Golant: "Pharm of 2020" - one of the most successful we realize programs in Russia

Practically all key indicators and identifiers which were declared on start of the state program of "Pharm of 2020" at the moment are successfully carried out. About it in the first day of the partnering-forum Life Sciences Invest. Partnering Russia, on November 9, the chairman of the board of NP Union of Pharmaceutical and Biomedical Clusters Zakhar Golant declared to journalists.

"Several months ago in St. Petersburg at an economic forum by the ministry of the industry and trade it was sounded that for the last three years in the Russian Federation 37 new pharmzavod appeared. It is difficult to call any other industry where 40 new plants appeared", - noted Golant.

The chairman of the board ON "The union of pharmaceutical and biomedical clusters" also added that over the past few years there was a large number of the companies which not just make products, but also administer new medicines.

"In general I can tell that the pharmaceutical industry over the past few years is, perhaps, the most high-growth industry in Russia", - added Golant.

Let's remind, the VI partnering-forum Life Sciences Invest. Partnering Russia passes on November 9-10. The organizer of a forum — the Union "Medico-pharmaceutical projects. 21st century". The action is traditionally supported by Committee on industrial policy and innovations of St. Petersburg, the Ministry of Economic Development, the Ministry of the industry and trade, the Ministry of Health of the Russian Federation, and also the Government of St. Petersburg. Partners of a forum – MSD Pharmaceuticals, LLC Novo Nordisk, CJSC Generium, LLC Samson-Med and NTFF "Polisan».

PHOTO